Financial Performance

The rise of independent 'Operator' models is untethering top earners from the city core, fueling a new wave of demand for luxury lifestyle communities.

Beyond the factory, China's manufacturers are now tech pioneers. The MEI Awards reveal a strategic shift that is reshaping global markets and supply chains.

NAVEE launches its rugged XT5 Pro scooter, challenging off-road rivals with a blend of high-performance tech, certified safety, and eco-friendly power.

How a strategic pharma pact between Duchesnay and Mochida to bring a vital pregnancy drug to Japan offers a blueprint for stable returns in complex markets.

Beyond software, a new accelerator offers hardware startups a rare advantage, bridging the gap from university labs to investor-ready prototypes.

A landmark green ammonia project in Spain offers a blueprint for industrial decarbonization, holding key strategic lessons for the biopharmaceutical sector.

VEON and Starlink's landmark satellite call in Kazakhstan isn't just a tech feat; it's an investment blueprint for the future of remote luxury.

With $86M in new funding, PolyAI is moving beyond chatbots to build autonomous AI systems. Here’s why it matters for your business strategy.

Fairholme's year-end dividends are more than just income. We dissect the funds' high-risk, non-diversified strategy and what it means for investors.

TPG RE Finance Trust declared a steady $0.24 dividend. We analyze if this signals portfolio resilience or a strategic play in a volatile market.

The safari park operator swung from a major loss to a $1.9M pre-tax profit, driven by revenue growth and the absence of prior-year proxy battle costs.

Your health plan is evolving beyond medical bills. Insurers are now funding doulas, food, and transport to tackle the root causes of poor health.

A top industrial firm offers a surprising blueprint for fixing healthcare's biggest challenges, from clinician burnout to supply chain woes.

A C$1M private placement for CHAR Technologies signals strong investor faith in its waste-to-energy tech, promising to decarbonize heavy industry.

Aligos Therapeutics is using strategic stock grants to lure top talent. Is this a savvy growth play or a creeping cost for shareholders? We break it down.

With its fourth acquisition under ZCG ownership, Unimed is consolidating the fragmented maritime health market, leveraging tech to create a dominant platform.

As China remembers the Nanjing Massacre, sculptor Wu Weishan's donated works serve as a powerful artistic cry for justice amid modern geopolitical tensions.

PSH continues its multi-billion dollar share repurchase strategy to tackle its stubborn stock discount. What does this mean for the fund and its future targets?

Colombia's energy giant Ecopetrol reshuffles key committees after high-profile resignations. Is this a strategic shift or a move to steady the ship?

Long Beach's new Black-Serving Institution status isn't just an equity win; it's a strategic investment in the diverse STEM talent America's defense sector needs.